Screener
Nuvation Bio NUVB Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
FAQ
- What is Nuvation Bio's total liabilities?
- Nuvation Bio (NUVB) reported total liabilities of $490.64M in Q2 2026.
- How has Nuvation Bio's total liabilities changed year-over-year?
- Nuvation Bio's total liabilities increased by 78.9% year-over-year, from $274.32M to $490.64M.
- What is the long-term trend for Nuvation Bio's total liabilities?
- Over 5 years (2020 to 2025), Nuvation Bio's total liabilities has grown at a 112.3% compound annual growth rate (CAGR), from $6.71M to $289.11M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Nuvation Bio's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude